Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2006
Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterizationFrank G Rücker, Lars Bullinger, Carsten Schwaenen, et al.Oncotarget|December 10, 2017
Protein phosphatase 4 regulatory subunit 2 (PPP4R2) is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.Science (New York, N.Y.)|February 1, 2020
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemiaHannah J Uckelmann, Stephanie M Kim, Eric M Wong, et al.Blood Advances|August 15, 2023
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technologyMarius-Konstantin Klever, Eric Sträng, Sara Hetzel, et al.Blood|May 25, 2013
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemiaJan Krönke, Lars Bullinger, Veronica Teleanu, et al.Blood|September 15, 2012
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicingAnna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, et al.Blood|December 22, 2011
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeFrank G Rücker, Richard F Schlenk, Lars Bullinger, et al.Nature Communications|May 4, 2019
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationSibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, et al.Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.Pageof 11